Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106K Sell
300
-800
-73% -$285K ﹤0.01% 892
2025
Q4
$360K Buy
1,100
+200
+22% +$63.4K ﹤0.01% 448
2025
Q3
$254K Buy
900
+200
+29% +$58K ﹤0.01% 559
2025
Q2
$195K Sell
700
-200
-22% -$56.7K ﹤0.01% 379
2025
Q1
$280K Buy
+900
New +$266K ﹤0.01% 416
2024
Q4
Sell
-500
Closed -$161K 384
2024
Q3
$161K Sell
500
-500
-50% -$164K ﹤0.01% 411
2024
Q2
$312K Buy
+1,000
New +$294K ﹤0.01% 364
2023
Q4
Sell
-14,100
Closed -$3.79M 311
2023
Q3
$3.79M Buy
14,100
+4,800
+52% +$1.2M 0.08% 111
2023
Q2
$2.06M Sell
9,300
-163,500
-95% -$37.9M 0.05% 139
2023
Q1
$41.8M Buy
172,800
+46,300
+37% +$11.4M 0.5% 39
2022
Q4
$33.2M Sell
126,500
-3,900
-3% -$1.05M 0.45% 52
2022
Q3
$29.4M Buy
130,400
+75,100
+136% +$18.2M 0.4% 52
2022
Q2
$13.5M Sell
55,300
-719,200
-93% -$176M 0.23% 113
2022
Q1
$187M Buy
+774,500
New +$178M 2.68% 6
2021
Q4
Sell
-17,000
Closed -$3.62M 211
2021
Q3
$3.62M Sell
17,000
-543,000
-97% -$125M 0.04% 285
2021
Q2
$137M Buy
560,000
+414,200
+284% +$102M 2.2% 9
2021
Q1
$36.3M Buy
+145,800
New +$34.8M 0.72% 29
2020
Q4
Sell
-19,900
Closed -$5.06M 281
2020
Q3
$5.06M Sell
19,900
-100
-0.5% -$24.8K 0.64% 46
2020
Q2
$4.72M Buy
20,000
+15,000
+300% +$3.42M 0.17% 137
2020
Q1
$1.01M Hold
5,000
0.04% 307
2019
Q4
$1.21M Buy
+5,000
New +$1.1M 0.03% 289

Other funds holding AMGN

Capula Management's AMGN Position: Q1 2026 in Review

Capula Management reduced its Amgen (AMGN) stake by 100% in Q1 2026, selling an estimated $39.2M and leaving 61 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

Capula Management first reported a position in AMGN in Q1 2021 and has held it in 16 quarters since. The position peaked at $93.6M in Q1 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capula Management held 61 shares of Amgen worth $21.5K as of Q1 2026.
  • Capula Management sold 109,965 Amgen shares in Q1 2026, an estimated $39.2M.
  • Amgen made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #1039 holding.
  • Capula Management first reported a position in Amgen in Q1 2021 and has held it in 16 quarters since.
  • Capula Management's Amgen position peaked at $93.6M in Q1 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.